Subtype
Malignant Intestinal Neoplasm
CI-CAN-00001137Explore in graph →
1,666 active trials21 approved drugs383 evidence items
- NCIt
- C4572
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001137Explore in graph →
Clinical trials
7,773 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (772)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00016133 | Vaccine Therapy in Treating Patients With Stage II or Stage III Colon Cancer That Has Been Removed During Surgery | completed | Phase 1 / Phase 2 | — | IntracelINDUSTRY | 1 | May 30, 2013 | clinicaltrials |
| NCT01289288 | A Physician-Based Trial to Increase Colorectal Cancer Screening in Chinese(CRC) | completed | Phase 1 / Phase 2 | 480 | Georgetown UniversityOTHER | 1 | May 21, 2013 | clinicaltrials |
| NCT00785122 | IMA910 Plus GM-CSF With Low-dose Cyclophosphamide Pre-treatment in Advanced Colorectal Carcinoma Patients Following a Successful 12 Week First-line Treatment With Oxaliplatin-based Chemotherapy (IMA910-101)(IMA910-101) | completed | Phase 1 / Phase 2 | 92 | Immatics Biotechnologies GmbHINDUSTRY | 9 | May 16, 2013 | clinicaltrials |
| NCT00006009 | Monoclonal Antibody Therapy in Treating Patients With Advanced or Recurrent Lymphoma | completed | Phase 1 | — | Stanford UniversityOTHER | 1 | May 15, 2013 | clinicaltrials |
| NCT00025142 | Gefitinib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors or Colorectal Cancer | completed | Phase 2 | — | Stanford UniversityOTHER | 1 | May 15, 2013 | clinicaltrials |
| NCT00707889 | Phase 2 Study of ABT-869 in Combination With mFOLFOX6 Versus Bevacizumab in Combination With mFOLFOX6 to Treat Advanced Colorectal Cancer | completed | Phase 2 | 159 | AbbVie (prior sponsor, Abbott)INDUSTRY | 14 | May 15, 2013 | clinicaltrials |
| NCT00111774 | Evaluating ABX-EGF in Patients With Metastatic ColorectalCarcinoma | completed | Phase 2 | 150 | AmgenINDUSTRY | 0 | May 14, 2013 | clinicaltrials |
| NCT00381173 | A Study of ZYC300 Administered With Cyclophosphamide Pre-Dosing | completed | Phase 1 | 22 | Eisai Inc.INDUSTRY | 1 | May 14, 2013 | clinicaltrials |
| NCT00780169 | Phase I Trial of Sorafenib + FOLFIRI In Metastatic Colorectal Cancer | completed | Phase 1 | 16 | Ottawa Hospital Research InstituteOTHER | 1 | May 13, 2013 | clinicaltrials |
| NCT00855946 | Proteomic Approach Using Matrix-assisted Laser Desorption/Ionization Tandem Time-of-flight (MALDI-TOF/TOF) of Tumor Response in Rectal Carcinoma After Radiochemotherapy(PROTEORECTUM) | completed | — | 46 | University Hospital, BordeauxOTHER | 1 | May 9, 2013 | clinicaltrials |
| NCT00290615 | Capecitabine, Cetuximab, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic or Recurrent Colorectal Cancer That Cannot Be Removed By Surgery | completed | Phase 2 | 30 | Herbert HurwitzOTHER | 1 | May 7, 2013 | clinicaltrials |
| NCT00005036 | Irinotecan Compared With Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer | completed | Phase 3 | 560 | National Cancer Institute (NCI)NIH | 1 | May 3, 2013 | clinicaltrials |
| NCT01341366 | Fast-track Perioperative Program for Laparoscopic Colorectal Surgery | completed | Phase 3 | 128 | Chinese University of Hong KongOTHER | 1 | Apr 30, 2013 | clinicaltrials |
| NCT00598156 | Chemotherapy and Avastin Followed by Maintenance Treatment With Avastin +/- Tarceva(ACT) | completed | Phase 3 | 249 | Lund University HospitalOTHER | 2 | Apr 22, 2013 | clinicaltrials |
| NCT01834742 | Pharmacodynamic Evaluation of Stool Output Following Oral Administration of Various Low Volume PEG3350-based Gut Cleansing Solutions Using the Split Dose Intake in Healthy Subjects(OUT) | completed | Phase 1 | 161 | NorgineINDUSTRY | 1 | Apr 18, 2013 | clinicaltrials |
| NCT01831310 | Nutrition for Colorectal Cancer Patients and Neutrophil Functions | completed | Phase 4 | 36 | Kocaeli UniversityOTHER | 1 | Apr 15, 2013 | clinicaltrials |
| NCT00005076 | Cetuximab and Irinotecan in Treating Patients With Advanced Colorectal Cancer | completed | Phase 2 | 110 | University of Alabama at BirminghamOTHER | 0 | Apr 12, 2013 | clinicaltrials |
| NCT00005094 | Celecoxib to Prevent Colorectal Cancer in Patients Who Have Undergone Surgery to Remove Polyps | completed | Phase 3 | 1,170 | National Cancer Institute (NCI)NIH | 1 | Apr 12, 2013 | clinicaltrials |
| NCT00033384 | CI-1040 in Treating Patients With Advanced Breast, Colon, Pancreatic, or Non-Small Cell Lung Cancer | completed | Phase 2 | — | University of Alabama at BirminghamOTHER | 1 | Apr 12, 2013 | clinicaltrials |
| NCT00897793 | Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial Cancer | completed | — | 25 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Apr 12, 2013 | clinicaltrials |
| NCT00089362 | Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Apr 10, 2013 | clinicaltrials |
| NCT00199654 | Positron Emission Tomography (PET) Interest in the Follow Up of Colorectal Cancer Stage II and III | completed | Phase 3 | 376 | University Hospital, LimogesOTHER | 1 | Apr 9, 2013 | clinicaltrials |
| NCT00258232 | Celecoxib, Capecitabine, and Irinotecan in Treating Patients With Recurrent or Metastatic Colorectal Cancer | completed | Phase 2 | — | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Apr 8, 2013 | clinicaltrials |
| NCT00369109 | Skin Biopsies and DNA Analysis in Patients Receiving Irinotecan or Gemcitabine For Advanced Solid Tumors | completed | — | 60 | Barbara Ann Karmanos Cancer InstituteOTHER | 2 | Apr 8, 2013 | clinicaltrials |
| NCT00002551 | SWOG-9304 Chemotherapy Plus Radiation Therapy in Treating Patients With Rectal Cancer That Has Been Surgically Removed | completed | Phase 3 | 1,917 | SWOG Cancer Research NetworkNETWORK | 3 | Apr 5, 2013 | clinicaltrials |
| NCT00003220 | Bryostatin 1 in Treating Patients With Metastatic Colorectal Cancer | completed | Phase 2 | — | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Apr 5, 2013 | clinicaltrials |
| NCT01324284 | Comparative Study of Lubiprostone and PEG Preparation Versus Conventional PEG Preparation for Colonoscopy(Lubiprostone) | completed | Phase 3 | 442 | Asian Institute of Gastroenterology, IndiaOTHER | 0 | Apr 5, 2013 | clinicaltrials |
| NCT00896896 | Immunoreactivity to Cetuximab in Cancer Patients | completed | — | 538 | Vanderbilt-Ingram Cancer CenterOTHER | 0 | Apr 2, 2013 | clinicaltrials |
| NCT00097578 | A Study of Avastin With Chemotherapy for Treatment of Metastatic or Advanced and Unresectable Colorectal Adenocarcinoma | completed | — | 1,953 | Genentech, Inc.INDUSTRY | 1 | Mar 28, 2013 | clinicaltrials |
| NCT00084643 | GTI-2040, Oxaliplatin, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer or Other Solid Tumors | completed | Phase 1 | 20 | National Cancer Institute (NCI)NIH | 1 | Mar 27, 2013 | clinicaltrials |
| NCT00003368 | Irinotecan in Treating Patients With Solid Tumors or Lymphoma Who Have Abnormal Liver or Kidney Function or Who Have Received Radiation Therapy to the Pelvis | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Mar 21, 2013 | clinicaltrials |
| NCT00026364 | ZD 1839 Plus Combination Chemotherapy in Treating Patients With Locally Advanced, Locally Recurrent, or Metastatic Colorectal Cancer | completed | Phase 1 | 22 | National Cancer Institute (NCI)NIH | 1 | Mar 21, 2013 | clinicaltrials |
| NCT01214512 | Performance Evaluation of the Micromedic CD24 in Vitro Diagnostic Assay | completed | — | 229 | Meir Medical CenterOTHER | 1 | Mar 12, 2013 | clinicaltrials |
| NCT00086931 | Oxaliplatin, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Rectum | completed | Phase 1 / Phase 2 | 37 | Roswell Park Cancer InstituteOTHER | 1 | Mar 8, 2013 | clinicaltrials |
| NCT01436617 | Assessing the Value of a Dosage of Anti-cetuximab in the Therapeutic Management of Patients With Colon Cancer or Upper Aero-digestive Tract and Candidates for Treatment With Cetuximab(IgES) | completed | — | 303 | Centre Francois BaclesseOTHER | 1 | Mar 8, 2013 | clinicaltrials |
| NCT00004066 | Gemcitabine, Docetaxel, and Filgrastim in Treating Patients With Recurrent or Persistent Leiomyosarcoma or Soft Tissue Sarcoma | completed | Phase 2 | 82 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 7, 2013 | clinicaltrials |
| NCT00003431 | Flt3L in Treating Patients With Metastatic Colorectal Cancer | completed | Phase 1 | — | Duke UniversityOTHER | 1 | Mar 5, 2013 | clinicaltrials |
| NCT00336960 | Celecoxib, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer That Can Be Removed By Surgery | completed | Phase 2 | 24 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Mar 5, 2013 | clinicaltrials |
| NCT01804621 | RCT to Examine the Effects of Scanning | completed | N/A | 15,824 | University of PennsylvaniaOTHER | 1 | Mar 5, 2013 | clinicaltrials |
| NCT00004074 | Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu | completed | Phase 1 | 15 | National Cancer Institute (NCI)NIH | 1 | Feb 28, 2013 | clinicaltrials |
| NCT00059891 | Anal Sphincter Prosthesis in Treating Patients Who Are Undergoing Surgery for Anal or Rectal Cancer | completed | N/A | 4 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 27, 2013 | clinicaltrials |
| NCT00004604 | Biological Therapy in Treating Patients With Metastatic Cancer | completed | Phase 1 | 24 | Duke UniversityOTHER | 1 | Feb 22, 2013 | clinicaltrials |
| NCT00004870 | Olimersen and Irinotecan in Treating Patients With Metastatic or Recurrent Colorectal Cancer | completed | Phase 1 / Phase 2 | — | The University of Texas Health Science Center at San AntonioOTHER | 1 | Feb 21, 2013 | clinicaltrials |
| NCT00202787 | Safety and Efficacy Study of Combination Therapy With Cetuximab and FOLFOX4 in Patients With Colorectal Cancer | completed | Phase 2 | 136 | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)OTHER | 1 | Feb 20, 2013 | clinicaltrials |
| NCT00335595 | Study of Bevacizumab Alone or Combined With Capecitabine and Oxaliplatin as Support Therapy in Metastatic Colorectal Cancer Patients | completed | Phase 3 | 480 | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)OTHER | 1 | Feb 20, 2013 | clinicaltrials |
| NCT01379872 | Assessment of New Radiation Oncology Technologies and Treatments(ANROTAT) | completed | — | 138 | Trans Tasman Radiation Oncology GroupOTHER | 1 | Feb 13, 2013 | clinicaltrials |
| NCT00693173 | Radiation Dosimetry Study Comparing 2 Different Patient Setups in Anal/Rectal Cancer Patients | completed | — | 14 | The University of Texas Medical Branch, GalvestonOTHER | 1 | Feb 12, 2013 | clinicaltrials |
| NCT00004189 | Rebeccamycin Analog and Cisplatin With or Without Filgrastim in Treating Patients With Advanced Cancer | completed | Phase 1 | 40 | National Cancer Institute (NCI)NIH | 1 | Feb 11, 2013 | clinicaltrials |
| NCT00005085 | Rebeccamycin Analog in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer | completed | Phase 2 | 37 | National Cancer Institute (NCI)NIH | 1 | Feb 11, 2013 | clinicaltrials |
| NCT00006221 | BMS-247550 in Treating Patients With Advanced Cancers | completed | Phase 1 | 54 | National Cancer Institute (NCI)NIH | 1 | Feb 11, 2013 | clinicaltrials |
Data updated 23 days agoSource updated May 30, 2013source: clinicaltrials